Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-01-29

Clinical Trial Update: Efficacy, Safety and Tolerability of Rotigotine Nasal Spray for the Acute Treatment of Parkinson Symptoms [Phase 2]

View source ↗

Summary

Phase 2 study evaluating efficacy, safety, and tolerability of rotigotine nasal spray for acute treatment of Parkinson's symptoms has completed. Results were po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rotigotine nasal spray (rotigotine)

Snippet

Sponsor: UCB Pharma | Conditions: Parkinson's Disease | Phase 2 | Status: COMPLETED | Results posted: 2010-01-29